ArticleLangenbeck's archives of surgery2025
Preoperative assessment of NIFTP clinicopathological characteristics and its impact on avoiding overtreatment.
Article in Langenbeck's archives of surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Clinical, ultrasonographic, and cytological characteristics of niftp and postoperative outcomes: a retrospective cohort study.Endocrine · 2026Article
- Current Evidence, Selective Indications, and the Role of Lymph-Node Assessment in Intraoperative Frozen Section in Thyroid Cancer Surgery: A Literature Review.Journal of clinical medicine · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeNon-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is a premalignant tumor formerly known as non-invasive encapsulated follicular variant of papillary thyroid carcinoma. The aim of this study was to investigate the clinicopathological traits of NIFTP to discern them from well-differentiated cancers and potentially avoid overtreatment.
methodsWe conducted a retrospective cohort study of NIFTP cases from July 2017 to November 2022 at our center. A review of demographic, clinical, sonographic, cytologic and surgical data was performed.
resultsDuring the study period 70 NIFTP cases were included. Among the cohort 74.3% (52/70) were women and the mean age was 55 years (range, 25–84). The majority of patients presented euthyroid (92.9%). Median NIFTP size was 2.5 cm (range, 1.0-10.8). Most nodules displayed low or intermediate risk on ultrasound being labeled EU-TIRADS 3 (46/70, 65.7%) and EU-TIRADS 4 (23/70, 32.9%). In cytology they were typically diagnosed as Bethesda III (15/70, 21.4%) or Bethesda IV (41/70, 58.6%). Regarding surgical procedures, 36 patients (51.4%) underwent lobo-isthmectomy and 34 patients (48.6%) received total thyroidectomy. Thirteen patients (18.6%) had coexisting microcarcinomas. No patients received radioiodine ablation. After a median follow-up of 27.5 months, no structural or biochemical recurrences were observed.
conclusionNon-suspect thyroid nodules on preoperative ultrasound when combined with an indeterminate cytology and altered molecular profile should raise awareness towards the possibility of NIFTP. Even though neither FNAB nor CNB are definitive for NIFTP, CNB may be considered when additional architectural assessment is needed. Management with lobectomy seems to suffice unless total thyroidectomy is justified.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.